INTRODUCTION

Selenium (Se) is an integral component of selenocysteine, a major structural amino-acid of selenoproteins [1]. In addition to its anti-oxidant and anti-inflammatory effects, Se is also involved in the synthesis of DNA and thyroid hormone [1]. The cytoprotective properties of selenoproteins have garnered much interest leading to the discovery of selenoenzymes such as glutathione peroxidase (GPx), thioredoxin reductase (TrxR), and iodothyronine deiodinases (IDDs) [2]. GPx, which is one of the most well-studied selenoprotein family members, functions as a part of a defense mechanism to protect polyunsaturated fatty acids from the damaging effects of free radicals and inhibits the production of proinflammatory cytokines, reactive oxygen species, and reactive nitrogen species [3].

Due to the anti-oxidative and anti-inflammatory properties of Se, numerous studies have assessed the relationship between Se levels and conditions commonly known to be associated with increased oxidative stress and inflammation such as cardiovascular and neurodegenerative diseases, diabetes mellitus (DM), and cancer [456]. The association between Se and DM is one of the most vigorously investigated [78]. Studies have mainly been conducted based on the assumption that Se may be protective against DM [9]. Oxidative stress and inflammation have been reported to be involved in the onset and progression of diabetes [1011]. Consistent with these findings, supplementation of antioxidants including Se has been shown to delay the onset of DM [6]. Moreover, data from isolated rat adipocytes show that Se in the form of selenate can act as an insulin mimetic [1213]. Several cell and animal studies have suggested that Se plays a crucial role in controlling glucose homeostasis [14151617]. Moreover, epidemiological studies have evaluated the effects of Se on DM, but the conclusions have been conflicting [181920212223]. Some studies report that Se is positively associated with DM [181920] while others indicate a negative or no association [212223]. Although there has been a meta-analysis including five observational studies [7], many additional studies have been published since then [18192425]. Hence, an updated meta-analysis to review the recent data is warranted to understand better and clarify the role of Se in DM. Therefore, we performed an updated meta-analysis by a comprehensive investigation of the literature with conflicting conclusions.

METHODS

Search strategy

The literature search was performed in accordance with the general principles recommended in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (Supplementary Table 1). Two independent investigators (S.M. and J.K.) searched the PubMed and Embase databases and selected articles using a combination of terms “diabetes mellitus” and “selenium.” Only articles published in English, before June 30, 2018, were included.

Study selection

The literature search yielded 2,085 potentially relevant articles, of which 1,734 were screened for further review after excluding duplicate studies. If studies had multiple reports, the latest or the complete article was enrolled. All articles were electronically downloaded and screened for inclusion using a two-step method. After evaluation of the titles and abstracts according to predefined criteria, 1,696 articles were excluded if: (1) the studies had a different topic of interest; (2) there was no information on Se and DM; or (3) the study was published as an abstract, expert opinion, conference article, or review. Subsequently, the full texts of 38 selected articles were reviewed by two independent investigators (S.M. and J.K.), and any disagreement was resolved by a third investigator (J.M.Y.). A total of 20 articles were finally selected for the meta-analysis (Fig. 1).

Assessment of bias risk

Three researchers independently assessed the methodological quality of the included articles using the Newcastle-Ottawa Scale (NOS) for case control studies [26]. Nine items were used to assess the quality, and all articles scored 6 to 8 (Supplementary Table 2). We concluded that the quality of these cross-sectional studies did not affect the quality of our meta-analysis.

Data extraction

The following variables were independently extracted by the two investigators based on the same rules: first author, publication year, country, number of study participants, mean age, number of men and women, characteristics of study participants including coexisting diseases, the mean or median concentration of Se, and number of DM.

Data analyses and statistical methods

We calculated the pooled odds ratio (OR) with 95% confidence intervals (CIs) for the highest and lowest quantiles of Se using the Mantel-Haenszel method. The Higgins' I² statistic was used to test for heterogeneity. When I² was ≤50%, the included studies were considered to have little heterogeneity, and a fixed-effects model was used. However, I² >50% indicated heterogeneity and a random-effects model was used. Subgroup and sensitivity analyses were used to determine the cause of heterogeneity. The potential for publication bias was assessed by funnel plot analysis. To examine the strength of the outcome, we conducted a sensitivity analysis to estimate the effects of the remaining studies without the larger one. All statistical analyses were calculated using the statistical program R (R version 3.1.0, 2014, www.r-project.org).

Ethical statement

This article does not contain examinations performed on human participants. Then, ethical approval was not necessary.

RESULTS

Characteristics of selected studies

Twenty articles were included in the meta-analysis [1819202122232425272829303132333435363738], and their main characteristics are summarized in Table 1. In total, 47,930 participants were enrolled, and 6,347 of them had DM. Sample sizes of these studies ranged from 128 to 8,876 participants. In these studies, Se concentrations were measured in the blood (n=13), nails (n=3), and urine (n=2). Two studies estimated Se intake from a food diary survey.

Se and DM

The meta-analysis found that high levels of Se were significantly associated with the presence of DM (OR, 1.88; 95% CI, 1.44 to 2.45). However, there was significant heterogeneity (I²=82%) (Fig. 2), and the funnel plot analysis showed significant publication bias (Supplementary Fig. 1). In the sensitivity analysis, the pooled OR changed little after omitting each study (Supplementary Fig. 2), and the heterogeneity ranged from 1.99 to 2.31, remaining statistically significant. A subgroup analysis based on the methods used for Se measurements, showed a significant association between high Se levels and DM in the studies on blood (OR, 2.17; 95% CI, 1.60 to 2.93; I²=77%), dietary intake (OR, 1.61; 95% CI, 1.10 to 2.36; I²=0%), and urine (OR, 1.49; 95% CI, 1.02 to 2.17; I²=0%). However, studies on Se in the nails failed to show a significant association with DM (OR, 1.24; 95% CI, 0.52 to 2.98; I²=91%). Because a significant heterogeneity was found in studies with blood, we conducted a sensitivity analysis and tested the publication bias. Sensitivity analysis found three outlier studies [343536]. After omitting these studies, the estimated pooled OR was 1.64 (95% CI, 1.34 to 2.02) with no significant heterogeneity (I²=40.3%). Since the funnel plot was asymmetric, publication bias was adjusted using the trim-and fill method by adding two estimated missing studies, which produced significant results (OR, 1.82; 95% CI, 1.31 to 2.53). Because of the heterogeneity in Se levels in each study, we conducted a subgroup analysis based on the mean or median blood Se levels, using 100 µg/L as the cut-off value. The pooled OR was 2.17 (95% CI, 1.37 to 3.44; I²=82%) in studies with mean Se <100 µg/L and 2.17 (95% CI, 1.40 to 3.39; I²=76%) in studies with mean Se ≥100 µg/L. A meta-regression analysis showed no significant effects of the mean Se levels (P=0.91) (Supplementary Fig. 3). The subgroup analysis using cut-off levels of Se of the highest group showed similar results (Table 2).

DISCUSSION

This meta-analysis of 20 observational studies showed that higher concentrations of Se were significantly associated with the presence of DM. Although significant heterogeneity was detected, the results did not change after adjustment by subgroup analysis, sensitivity analysis, and trim and fill analysis for publication bias.

DM is characterized by peripheral insulin resistance, with defects in insulin-secretion, which can be of varying degrees of severity. Although the mechanisms that underlie insulin resistance and diabetes are not fully understood, several studies point to the role of oxidative stress in the onset and progression of DM [10]. Therefore, Se which has been long touted for its antioxidant properties was believed to prevent the onset of DM by counteracting oxidative stress [9]. Although earlier studies have shown the insulin-mimetic and anti-diabetic effects of Se [1639], recent experimental studies have revealed an unexpected association between high Se intake and insulin resistance or DM [4041424344]. High Se exposure led to insulin resistance in rodents and pigs [45]. Although the mechanism underlying the diabetogenic effects of Se remains unclear, the high Se exposure might affect the expression of key regulators of glycolysis and gluconeogenesis. This action might potentially be mediated by the selenoprotein GPx-1 [45], as demonstrated by studies showing that overexpression of GPx-1 causes insulin resistance [46]. In skeletal muscles of pigs, high Se exposure led to an increase in GPx activity and expression of both forkhead box O1 and peroxisomal proliferator-activated receptor-γ coactivator 1α genes. It also led to a decrease in the expression of the gene for the glycolytic enzyme pyruvate kinase [44].

A number of human studies have been conducted to evaluate the effects of Se on DM, but the conclusions have been inconsistent. Although previous meta-analyses showed a modest association between Se and DM, they included only five observational studies [7]. Therefore, this meta-analysis is noteworthy since it demonstrates an association between Se and the presence of DM based on a number of observational studies in large populations, providing significant epidemiological evidence to support the results of previous experimental studies.

Although our findings suggest that there is a significant association between increased exposure to Se and DM, data from clinical trials of Se supplementation have not been conclusive. The first large randomized trial was the Nutritional Prevention of Cancer (NPC) Trial, in which 200 µg Se per day or a matched placebo was administered to evaluate whether it could reduce the risk of non-melanoma skin cancer. Stranges et al. [47] performed the secondary analyses with the NPC data and showed an increased risk of DM among those in the Se intervention group compared to those in the placebo group. In contrast to the NPC trial, the Se and Vitamin E Cancer Prevention Trial (SELECT), the largest prostate cancer prevention trial with 35,533 participants showed no significant increase in the risk for DM after supplementation with 200 µg/day of Se compared to placebo [48]. However, in a subgroup analysis with the elderly aged >63 years, a significantly increased risk for DM was reported [49]. Mao et al. [8] on the other hand, showed no association between Se supplementation (200 µg/day) and the risk for DM in their meta-analysis with four randomized controlled trial studies.

The considerable strengths of this study are that a number of observational studies with large populations were included, and predefined subgroup analyses could be performed. However, the present study has some limitations. First, since most of the included studies were cross-sectional studies, further prospective studies will be needed to clarify the relationship between Se and the risk for DM. Second, the differences in age, sex ratio and Se concentrations between different studies could induce a bias. In addition, the different methods used for measuring Se levels could also have contributed to the bias. Third, because we compared the highest quantile of Se to the lowest quantile in each study, there might be great heterogeneity among the cases and control groups between different studies.

In conclusion, this meta-analysis demonstrates that high levels of Se are associated with the presence of DM. Although the mechanism remains unclear, our findings could have implications for nutritional supplementation in clinical settings. Further prospective and randomized controlled trials are warranted to elucidate the link between Se and DM better.

NOTES

CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.

AUTHOR CONTRIBUTIONS:

• Conception or design: J.K., J.M.Y., S.M.

• Acquisition, analysis, or interpretation of data: J.K., J.M.Y., S.M.

• Drafting the work or revising: J.K., S.M.

• Final approval of the manuscript: J.K., H.S.C., M.K.C., Y.K.R., H.J.Y., J.H.P., D.S.K., J.M.Y., S.M.

SUPPLEMENTARY MATERIALS

REFERENCES

• 1. Mehdi Y, Hornick JL, Istasse L, Dufrasne I. Selenium in the environment, metabolism and involvement in body functions. Molecules 2013;18:3292-3311. ArticlePubMedPMC
• 2. Tapiero H, Townsend DM, Tew KD. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 2003;57:134-144. ArticlePubMedPMC
• 3. Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Bjorkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology 2012;55:1112-1121. ArticlePubMed
• 4. Nève J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 1996;3:42-47. ArticlePubMed
• 5. Rayman MP. Selenium and human health. Lancet 2012;379:1256-1268. ArticlePubMed
• 6. Steinbrenner H, Sies H. Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta 2009;1790:1478-1485. ArticlePubMed
• 7. Wang XL, Yang TB, Wei J, Lei GH, Zeng C. Association between serum selenium level and type 2 diabetes mellitus: a non-linear dose-response meta-analysis of observational studies. Nutr J 2016;15:48ArticlePubMedPMCPDF
• 8. Mao S, Zhang A, Huang S. Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Endocrine 2014;47:758-763. ArticlePubMedPDF
• 9. Ogawa-Wong AN, Berry MJ, Seale LA. Selenium and metabolic disorders: an emphasis on type 2 diabetes risk. Nutrients 2016;8:80ArticlePubMedPMC
• 10. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006;440:944-948. ArticlePubMedPDF
• 11. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24-38. ArticlePubMed
• 12. Ezaki O. The insulin-like effects of selenate in rat adipocytes. J Biol Chem 1990;265:1124-1128. ArticlePubMed
• 13. Hei YJ, Farahbakhshian S, Chen X, Battell ML, McNeill JH. Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Mol Cell Biochem 1998;178:367-375. PubMed
• 14. Furnsinn C, Englisch R, Ebner K, Nowotny P, Vogl C, Waldhausl W. Insulin-like vs. non-insulin-like stimulation of glucose metabolism by vanadium, tungsten, and selenium compounds in rat muscle. Life Sci 1996;59:1989-2000. ArticlePubMed
• 15. Mueller AS, Pallauf J. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J Nutr Biochem 2006;17:548-560. ArticlePubMed
• 16. McNeill JH, Delgatty HL, Battell ML. Insulinlike effects of sodium selenite in streptozocin-induced diabetic rats. Diabetes 1991;40:1675-1678. ArticlePubMed
• 17. Becker DJ, Reul B, Ozcelikay AT, Buchet JP, Henquin JC, Brichard SM. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia 1996;39:3-11. ArticlePubMedPDF
• 18. Kohler LN, Florea A, Kelley CP, Chow S, Hsu P, Batai K, Saboda K, Lance P, Jacobs ET. Higher plasma selenium concentrations are associated with increased odds of prevalent type 2 diabetes. J Nutr 2018;148:1333-1340. ArticlePubMedPMC
• 19. Li XT, Yu PF, Gao Y, Guo WH, Wang J, Liu X, Gu AH, Ji GX, Dong Q, Wang BS, Cao Y, Zhu BL, Xiao H. Association between plasma metal levels and diabetes risk: a case-control study in China. Biomed Environ Sci 2017;30:482-491. PubMed
• 20. Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Environ Health Perspect 2009;117:1409-1413. ArticlePubMedPMC
• 21. Park K, Rimm EB, Siscovick DS, Spiegelman D, Manson JE, Morris JS, Hu FB, Mozaffarian D. Toenail selenium and incidence of type 2 diabetes in U.S. men and women. Diabetes Care 2012;35:1544-1551. ArticlePubMedPMCPDF
• 22. Hansen AF, Simic A, Asvold BO, Romundstad PR, Midthjell K, Syversen T, Flaten TP. Trace elements in early phase type 2 diabetes mellitus: a population-based study. The HUNT study in Norway. J Trace Elem Med Biol 2017;40:46-53. ArticlePubMed
• 23. Gao H, Hagg S, Sjogren P, Lambert PC, Ingelsson E, van Dam RM. Serum selenium in relation to measures of glucose metabolism and incidence of type 2 diabetes in an older Swedish population. Diabet Med 2014;31:787-793. ArticlePubMed
• 24. Yuan Y, Xiao Y, Yu Y, Liu Y, Feng W, Qiu G, Wang H, Liu B, Wang J, Zhou L, Liu K, Xu X, Yang H, Li X, Qi L, Zhang X, He M, Hu FB, Pan A, Wu T. Associations of multiple plasma metals with incident type 2 diabetes in Chinese adults: the Dongfeng-Tongji Cohort. Environ Pollut 2018;237:917-925. ArticlePubMed
• 25. Galan-Chilet I, Grau-Perez M, De Marco G, Guallar E, Martin-Escudero JC, Dominguez-Lucas A, Gonzalez-Manzano I, Lopez-Izquierdo R, Briongos-Figuero LS, Redon J, Chaves FJ, Tellez-Plaza M. A gene-environment interaction analysis of plasma selenium with prevalent and incident diabetes: The Hortega study. Redox Biol 2017;12:798-805. ArticlePubMedPMC
• 26. Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, McNeil J, Moher D, Mack D, Patel D. Celiac disease. Evid Rep Technol Assess (Summ) 2004;104:1-6.
• 27. Zhang H, Yan C, Yang Z, Zhang W, Niu Y, Li X, Qin L, Su Q. Alterations of serum trace elements in patients with type 2 diabetes. J Trace Elem Med Biol 2017;40:91-96. ArticlePubMed
• 28. Skalnaya MG, Skalny AV, Yurasov VV, Demidov VA, Grabeklis AR, Radysh IV, Tinkov AA. Serum trace elements and electrolytes are associated with fasting plasma glucose and HbA(1c) in postmenopausal women with type 2 diabetes mellitus. Biol Trace Elem Res 2017;177:25-32. ArticlePubMedPDF
• 29. Lu CW, Chang HH, Yang KC, Kuo CS, Lee LT, Huang KC. High serum selenium levels are associated with increased risk for diabetes mellitus independent of central obesity and insulin resistance. BMJ Open Diabetes Res Care 2016;4:e000253.ArticlePubMedPMC
• 30. Alehagen U, Johansson P, Bjornstedt M, Rosen A, Post C, Aaseth J. Relatively high mortality risk in elderly Swedish subjects with low selenium status. Eur J Clin Nutr 2016;70:91-96. ArticlePubMedPDF
• 31. Stranges S, Galletti F, Farinaro E, D'Elia L, Russo O, Iacone R, Capasso C, Carginale V, De Luca V, Della Valle E, Cappuccio FP, Strazzullo P. Associations of selenium status with cardiometabolic risk factors: an 8-year follow-up analysis of the Olivetti Heart study. Atherosclerosis 2011;217:274-278. ArticlePubMed
• 32. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care 2007;30:829-834. ArticlePubMedPDF
• 33. Su LQ, Jin YL, Unverzagt FW, Cheng YB, Hake AM, Ran L, Ma F, Liu JY, Chen C, Bian JC, Wu XP, Gao S. Nail selenium level and diabetes in older people in rural China. Biomed Environ Sci 2016;29:818-824. PubMed
• 34. Vinceti M, Grioni S, Alber D, Consonni D, Malagoli C, Agnoli C, Malavolti M, Pala V, Krogh V, Sieri S. Toenail selenium and risk of type 2 diabetes: the ORDET cohort study. J Trace Elem Med Biol 2015;29:145-150. ArticlePubMed
• 35. Liu B, Feng W, Wang J, Li Y, Han X, Hu H, Guo H, Zhang X, He M. Association of urinary metals levels with type 2 diabetes risk in coke oven workers. Environ Pollut 2016;210:1-8. ArticlePubMed
• 36. Feng W, Cui X, Liu B, Liu C, Xiao Y, Lu W, Guo H, He M, Zhang X, Yuan J, Chen W, Wu T. Association of urinary metal profiles with altered glucose levels and diabetes risk: a population-based study in China. PLoS One 2015;10:e0123742. ArticlePubMedPMC
• 37. Wei J, Zeng C, Gong QY, Yang HB, Li XX, Lei GH, Yang TB. The association between dietary selenium intake and diabetes: a cross-sectional study among middle-aged and older adults. Nutr J 2015;14:18ArticlePubMedPMCPDF
• 38. Stranges S, Sieri S, Vinceti M, Grioni S, Guallar E, Laclaustra M, Muti P, Berrino F, Krogh V. A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health 2010;10:564ArticlePubMedPMCPDF
• 39. Stapleton SR. Selenium: an insulin-mimetic. Cell Mol Life Sci 2000;57:1874-1879. ArticlePubMedPDF
• 40. Rasekh HR, Potmis RA, Nonavinakere VK, Early JL, Iszard MB. Effect of selenium on plasma glucose of rats: role of insulin and glucocorticoids. Toxicol Lett 1991;58:199-207. ArticlePubMed
• 41. Mueller AS, Bosse AC, Most E, Klomann SD, Schneider S, Pallauf J. Regulation of the insulin antagonistic protein tyrosine phosphatase 1B by dietary Se studied in growing rats. J Nutr Biochem 2009;20:235-247. ArticlePubMed
• 42. Zeng MS, Li X, Liu Y, Zhao H, Zhou JC, Li K, Huang JQ, Sun LH, Tang JY, Xia XJ, Wang KN, Lei XG. A high-selenium diet induces insulin resistance in gestating rats and their offspring. Free Radic Biol Med 2012;52:1335-1342. ArticlePubMedPMC
• 43. Liu Y, Zhao H, Zhang Q, Tang J, Li K, Xia XJ, Wang KN, Li K, Lei XG. Prolonged dietary selenium deficiency or excess does not globally affect selenoprotein gene expression and/or protein production in various tissues of pigs. J Nutr 2012;142:1410-1416. ArticlePubMedPMC
• 44. Pinto A, Juniper DT, Sanil M, Morgan L, Clark L, Sies H, Rayman MP, Steinbrenner H. Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J Inorg Biochem 2012;114:47-54. ArticlePubMed
• 45. Zhou J, Huang K, Lei XG. Selenium and diabetes: evidence from animal studies. Free Radic Biol Med 2013;65:1548-1556. ArticlePubMed
• 46. McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, Lei XG. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci U S A 2004;101:8852-8857. ArticlePubMedPMC
• 47. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007;147:217-223. ArticlePubMed
• 48. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51. ArticlePubMed
• 49. Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez ME, Alberts DS, Lance P. Selenium supplementation for prevention of colorectal adenomas and risk of associated type 2 diabetes. J Natl Cancer Inst 2016;108:djw152. ArticlePubMedPMC

Fig. 1

Representation of the search strategy. DM, diabetes mellitus.

Fig. 2

Forest plots summarizing the odds ratio (OR) of the association between Se levels and the presence of diabetes mellitus. CI, confidence interval.

Table 1

Summary of the 20 observational studies included in the present meta-analysis

Study	Location	Design	Study population	No. of subjects	No. of DM (%)	Age, yr, mean or median	Selenium concentration, mean or median	Selenium measurement	Selenium classification
Yuan et al. (2018) [24]	China	Cross-sectional	Population based	2,078	1,039 (50)	Controls: 62.8	Controls: 61.7	Blood, μg/L	Quartile
					1:1 match	Cases: 62.9	Cases: 64.3
Kohler et al. (2018) [18]	USA	Cross-sectional	Population based	1,727	172 (10)	63.1	139.8	Blood, μg/L	Tertile
Li et al. (2017) [19]	China	Cross-sectional	Population based	551	122 (22.1)	66.4	16.4	Blood, μg/L	Tertile
Galan-Chilet et al. (2017) [25]	Spain	Cross-sectional	Population based	1,,452	120	49	84.2	Blood, μg/L	Tertile
Hansen et al. (2017) [22]	Norway	Cross-sectional	Population based	883	128	Controls: 61.4	Controls: 101.4a	Blood, μg/L	Quartile
						Cases: 65.2	Cases: 101.2a
Zhang et al. (2017) [27]	China	Cross-sectional	Population based	1,837	510	Controls: 55.2	Controls: 200	Blood, μg/L	Quartile
						Cases: 57.7	Cases: 210
Skalnaya et al. (2017) [28]	Russia	Cross-sectional	Population based	128	64 (50)	Controls: 56.7	Controls: 110.2	Blood, μg/L	Median
			Menopausal women		1:1 match	Cases: 55.8	Cases: 126.8
Lu et al. (2016) [29]	Taiwan	Cross-sectional	Hospital, 40 yr or older	847	303 (35.8)	63.9	86.7a	Blood, μg/L	Quartile
					1:2 match
Alehagen et al. (2016) [30]	Sweden	Cross-sectional	Population based	668	146	NA	67.1	Blood, μg/L	Quartile
			70–80 yr
Gao et al. (2014) [23]	Sweden	Cohort	Population based	1,539	53 (for 10 yr)	49.7	75.6	Blood, μg/L	Tertile
Stranges et al. (2011) [31]	Italy	Cross-sectional	Population based	445	13	50.9	77.5	Blood, μg/L	Tertile
Laclaustra et al. (2009) [20]	USA	Cross-sectional	Population based	917	121	54.2	137.1	Blood, μg/L	Quartile
Bleys et al. (2007) [32]	USA	Cross-sectional	Population based	8,876	1,379	Controls: 42.8	Controls: 125.7	Blood, μg/L	Quintile
						Cases: 58.3	Cases: 126.5
Su et al. (2016) [33]	China	Cross-sectional	Population based	1,856	163	74	0.461a	Nail, μg/g	Quartile
			65 yr or older
Vinceti et al. (2015) [34]	Italy	Cross-sectional	Population based	621	226	Controls: 50.9	0.57	Nail, μg/g	Quartile
			Women, 35–70 yr			Cases: 51.2
Park et al. (2012) [21]	USA	Cohort	Population based	Men: 3,535	780	Men: 59.6	Men: 0.84	Nail, μg/g	Quintile
			Nurses, 30–55 yr	Women: 3,630		Women: 52.6	Women: 0.77
			Health professional, 40–75 yr
Liu et al. (2016) [35]	China	Cross-sectional	The coke oven workers	1,493	102	Controls: 41.8	Controls: 10	Urine, μg/L	Tertile
						Cases: 47	Cases: 11.5
Feng et al. (2015) [36]	China	Cross-sectional	Population based	2,242	218	53	7.42a	Urine, μg/L	Quartile
Wei et al. (2015) [37]	China	Cross-sectional	Population based	5,423	525	Controls: 52.9	Controls: 43.2	Intake, μg/day	Quartile
			40 yr or older			Cases: 54.7	Cases: 46.8
Stranges et al. (2010) [39]	Italy	Cohort	Population based	7,182	253	Controls: 47.1	Controls: 56.8	Intake, μg/day	Quintile
			Healthy women, 34–70 yr			Cases: 51.2	Cases: 60.9

QuintileDM, diabetes mellitus; NA, not available.

^aMedian.

Table 2

The OR of the association between Se levels and the presence of DM by cut-off levels of Se of the highest group

Cut-off value of Se level of highest group	No. of studies	OR (95% CI)	Heterogeneity (I2), %
<100 μg/L	6	1.90 (1.23–2.93)	74
100–120 μg/L	2	4.06 (2.67–6.18)	0
>120 μg/L	4	2.46 (1.48–4.10)	79

OR, odds ratio; Se, selenium; DM, diabetes mellitus; CI, confidence interval.

Figure & Data

References

Citations

Citations to this article as recorded by  

• Increased Expression of PHGDH Under High-Selenium Stress In Vivo
  Qin Wang, Jianrong Wang, Xue Zhang, Yiqun Liu, Feng Han, Xuesong Xiang, Yanbin Guo, Zhen-wu Huang
  Biological Trace Element Research.2024;[Epub]     CrossRef
• Dosage-effect of selenium supplementation on blood glucose and oxidative stress in type 2 diabetes mellitus and normal mice
  Xiaxia Cai, Zhuo Hu, Mingyuan Zhang, Qinyu Dang, Qian Yang, Xiaoyan Zhao, Yandi Zhu, Yadi Zhang, Yuchen Wei, Haiqin Fang, Huanling Yu
  Journal of Trace Elements in Medicine and Biology.2024; 83: 127410.     CrossRef
• Immunomodulation through Nutrition Should Be a Key Trend in Type 2 Diabetes Treatment
  Katarzyna Napiórkowska-Baran, Paweł Treichel, Marta Czarnowska, Magdalena Drozd, Kinga Koperska, Agata Węglarz, Oskar Schmidt, Samira Darwish, Bartłomiej Szymczak, Zbigniew Bartuzi
  International Journal of Molecular Sciences.2024; 25(7): 3769.     CrossRef
• Biological Activity of Selenium and Its Impact on Human Health
  Giuseppe Genchi, Graziantonio Lauria, Alessia Catalano, Maria Stefania Sinicropi, Alessia Carocci
  International Journal of Molecular Sciences.2023; 24(3): 2633.     CrossRef
• The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endometrial and Ovarian Cancer
  Anna Golara, Mateusz Kozłowski, Paweł Guzik, Sebastian Kwiatkowski, Aneta Cymbaluk-Płoska
  International Journal of Molecular Sciences.2023; 24(13): 10887.     CrossRef
• Association of Selenium Intake and Selenium Concentrations with Risk of Type 2 Diabetes in Adults: A Narrative Review
  Maha Alharithy, Nora Alafif
  Metabolites.2023; 13(6): 767.     CrossRef
• Selenium-Containing Organic Fertilizer Application Affects Yield, Quality, and Distribution of Selenium in Wheat
  Peng Chen, Hiba Shaghaleh, Yousef Alhaj Hamoud, Jing Wang, Wenxia Pei, Xianfu Yuan, Jianjian Liu, Cece Qiao, Wenhui Xia, Jianfei Wang
  Life.2023; 13(9): 1849.     CrossRef
• Selenium Species in Diabetes Mellitus Type 2
  Krystyna Pyrzynska, Aleksandra Sentkowska
  Biological Trace Element Research.2023;[Epub]     CrossRef
• A Comprehensive Review on Selenium and Its Effects on Human Health and Distribution in Middle Eastern Countries
  Marek Kieliszek, Iqra Bano, Hamed Zare
  Biological Trace Element Research.2022; 200(3): 971.     CrossRef
• Selenium and clarithromycin loaded PLA-GO composite wound dressings by electrospinning method
  Fatih Ciftci, Sumeyra Ayan, Nilüfer Duygulu, Yasemin Yilmazer, Zeynep Karavelioglu, Meyrem Vehapi, Rabia Cakır Koc, Mustafa Sengor, Hakan Yılmazer, Didem Ozcimen, Oguzhan Gunduz, Cem Bulent Ustundag
  International Journal of Polymeric Materials and Polymeric Biomaterials.2022; 71(12): 898.     CrossRef
• The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities
  Holger Steinbrenner, Leonidas H. Duntas, Margaret P. Rayman
  Redox Biology.2022; 50: 102236.     CrossRef
• The Role of Selenium in Pathologies: An Updated Review
  Giulia Barchielli, Antonella Capperucci, Damiano Tanini
  Antioxidants.2022; 11(2): 251.     CrossRef
• Selenium and Selenoproteins at the Intersection of Type 2 Diabetes and Thyroid Pathophysiology
  Francesca Gorini, Cristina Vassalle
  Antioxidants.2022; 11(6): 1188.     CrossRef
• Higher selenium was associated with higher risk of diabetes: Consistent evidence from longitudinal and cross-sectional studies based on nail and serum selenium measures
  Ranqi Shao, Liqin Su, Li Li, Jinghuan Wu, Xiaohong He, Deqian Mao, Yibin Cheng, Jingyi Liu, Chen Chen, Yinlong Jin, Sujuan Gao
  Science of The Total Environment.2022; 840: 156618.     CrossRef
• The Roles and Pathogenesis Mechanisms of a Number of Micronutrients in the Prevention and/or Treatment of Chronic Hepatitis, COVID-19 and Type-2 Diabetes Mellitus
  Khalid M. Sumaily
  Nutrients.2022; 14(13): 2632.     CrossRef
• Associations between Circulating SELENOP Level and Disorders of Glucose and Lipid Metabolism: A Meta-Analysis
  Ruirui Yu, Zhoutian Wang, Miaomiao Ma, Ping Xu, Longjian Liu, Alexey A. Tinkov, Xin Gen Lei, Ji-Chang Zhou
  Antioxidants.2022; 11(7): 1263.     CrossRef
• Cross-Sectional Association of Blood Selenium with Glycemic Biomarkers among U.S. Adults with Normoglycemia in the National Health and Nutrition Examination Survey 2013–2016
  Jingli Yang, En Chen, Cheukling Choi, Kayue Chan, Qinghua Yang, Juwel Rana, Bo Yang, Chuiguo Huang, Aimin Yang, Kenneth Lo
  Nutrients.2022; 14(19): 3972.     CrossRef
• Plasma and vitreous selenium concentrations in patients with type 2 diabetes and diabetic retinopathy
  Chunmiao Wang, Ruijin Ran, Xin Jin, Xiaohong Zhu
  Medicine.2022; 101(39): e30877.     CrossRef
• Emerging roles of selenium on metabolism and type 2 diabetes
  Jiuxiang Zhao, Hong Zou, Yanling Huo, Xiaoyi Wei, Yu Li
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Selenium: Role in preserving and improving health and preventing disease
  Goran Belojević
  Galenika Medical Journal.2022; 1(4): 90.     CrossRef
• A comprehensive review on the neuropathophysiology of selenium
  Mohammad Naderi, Pankaj Puar, Mahtab Zonouzi-Marand, Douglas P. Chivers, Som Niyogi, Raymond W.M. Kwong
  Science of The Total Environment.2021; 767: 144329.     CrossRef
• Dietary selenium intake and risk of hospitalization for type 2 diabetes in the Moli-sani study cohort
  Marco Vinceti, Marialaura Bonaccio, Tommaso Filippini, Simona Costanzo, Lauren A. Wise, Augusto Di Castelnuovo, Emilia Ruggiero, Mariarosaria Persichillo, Chiara Cerletti, Maria Benedetta Donati, Giovanni de Gaetano, Licia Iacoviello
  Nutrition, Metabolism and Cardiovascular Diseases.2021; 31(6): 1738.     CrossRef
• A systematic review and dose-response meta-analysis of exposure to environmental selenium and the risk of type 2 diabetes in nonexperimental studies
  Marco Vinceti, Tommaso Filippini, Lauren A. Wise, Kenneth J. Rothman
  Environmental Research.2021; 197: 111210.     CrossRef
• Selenium as a Bioactive Micronutrient in the Human Diet and Its Cancer Chemopreventive Activity
  Dominika Radomska, Robert Czarnomysy, Dominik Radomski, Anna Bielawska, Krzysztof Bielawski
  Nutrients.2021; 13(5): 1649.     CrossRef
• Selenium in Human Health and Gut Microflora: Bioavailability of Selenocompounds and Relationship With Diseases
  Rannapaula Lawrynhuk Urbano Ferreira, Karine Cavalcanti Maurício Sena-Evangelista, Eduardo Pereira de Azevedo, Francisco Irochima Pinheiro, Ricardo Ney Cobucci, Lucia Fatima Campos Pedrosa
  Frontiers in Nutrition.2021;[Epub]     CrossRef
• Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?
  Jia-Yue Duan, Xiao Lin, Feng Xu, Su-Kang Shan, Bei Guo, Fu-Xing-Zi Li, Yi Wang, Ming-Hui Zheng, Qiu-Shuang Xu, Li-Min Lei, Wen-Lu Ou-Yang, Yun-Yun Wu, Ke-Xin Tang, Ling-Qing Yuan
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• Selenium Intake and Glycemic Control in Young Adults With Normal-Weight Obesity Syndrome
  Acsa de Castro Santos, Anna Flavia Ferreira Passos, Luciana Carla Holzbach, Cristiane Cominetti
  Frontiers in Nutrition.2021;[Epub]     CrossRef
• Development and Therapeutic Potential of Selenazo Compounds
  Ana Carolina Ruberte, Carmen Sanmartin, Carlos Aydillo, Arun K. Sharma, Daniel Plano
  Journal of Medicinal Chemistry.2020; 63(4): 1473.     CrossRef
• Selenium in thyroid disorders — essential knowledge for clinicians
  Kristian Hillert Winther, Margaret Philomena Rayman, Steen Joop Bonnema, Laszlo Hegedüs
  Nature Reviews Endocrinology.2020; 16(3): 165.     CrossRef
• Safety of selenium‐enriched biomass of Yarrowia lipolytica as a novel food pursuant to Regulation (EU) 2015/2283
  Dominique Turck, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch‐Ernst, John Kearney, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marc
  EFSA Journal.2020;[Epub]     CrossRef

• The Association of Circulating Selenium Concentrations with Diabetes Mellitus

  
  Xiao-Long Liao, Zhong-Hua Wang, Xiu-Na Liang, Jun Liang, Xue-Biao Wei, Shou-Hong Wang, Wei-Xin Guo
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4755.     CrossRef
• A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Hashimoto’s Thyroiditis
  Kristian Hillert Winther, Enrico Papini, Roberto Attanasio, Roberto Negro, Laszlo Hegedüs
  European Thyroid Journal.2020; 9(2): 99.     CrossRef
• Systems Biology of Selenium and Complex Disease
  Huimin Ying, Yan Zhang
  Biological Trace Element Research.2019; 192(1): 38.     CrossRef
• Effectiveness and safety of selenium supplementation for type 2 diabetes mellitus in adults: a systematic review of randomised controlled trials
  A. Stróżyk, Z. Osica, J. D. Przybylak, M. Kołodziej, B. M. Zalewski, B. Mrozikiewicz‐Rakowska, H. Szajewska
  Journal of Human Nutrition and Dietetics.2019; 32(5): 635.     CrossRef
• Selenium and Health: An Update on the Situation in the Middle East and North Africa
  Sohayla A. Z. Ibrahim, Abdelhamid Kerkadi, Abdelali Agouni
  Nutrients.2019; 11(7): 1457.     CrossRef